Antibody and CD8+ T cell responses against HER2/neu required for tumor eradication after DNA immunization with a Flt-3 ligand fusion vaccine. [electronic resource]
Producer: 20071227Description: 6195-203 p. digitalISSN:- 1078-0432
- Animals
- CD8-Positive T-Lymphocytes -- immunology
- COS Cells
- Cancer Vaccines
- Cell Line, Tumor
- Chlorocebus aethiops
- DNA -- chemistry
- Female
- Humans
- Ligands
- Membrane Proteins -- chemistry
- Mice
- Microscopy, Fluorescence
- Neoplasm Transplantation
- Neuraminidase -- chemistry
- Protein Structure, Tertiary
- T-Lymphocytes -- metabolism
- Time Factors
- Vaccines, DNA -- chemistry
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.